Diclofenac Potassium 50 MG + Para 325 MG + Chlorzoxazone 20 MG Tabs

Diclofenac Potassium 50 MG + Para 325 MG + Chlorzoxazone 20 MG Tabs is a pharmacy tablet formulation manufactured with Diclofenac Potassium, Paracetamol and Chlorzoxazone. This formulation has a good standing in general medicine & pain management product segment. A combination of 3 active ingredients give a tablet a very strong formulation identity, and the product becomes an integral part of the portfolio for a pharma company.

This tablet formulation is mostly covered by those companies dealing in PCD pharma franchise, third party manufacturing, branded marketing, pharmaceutical distribution and also by other similar segments. The tablet formulation format makes it easy to pack, store, supply, and distribute across varied market channels. Manufactured by following proper quality parameters and packaging, Diclofenac Potassium 50 MG + Para 325 MG + Chlorzoxazone 20 MG Tabs, becomes an integral product in the pharma category.

Composition Profile & Tablet strength

Diclofenac Potassium 50 mg, Paracetamol 325 mg and Chlorzoxazone 20 mg forms the base composition in this tablet formulation. Diclofenac Potassium is a widely recognized active ingredient, and paracetamol is one of the most popular in general medicine category while chlorzoxazone adds value in the product profile. Combining three such active components the dosage forms becomes a well demanded one in the market.

The tablet formulation usually carries suitable excipients which helps it hold on its shape, size, strength, stability, disintegration time and shelf life. These components give proper product uniformity through every dosage form, maintaining good consistent product strength.

Quality manufacturing & standards processing

Diclofenac Potassium 50 MG + Para 325 MG + Chlorzoxazone 20 MG Tabs are supposed to be manufactured at strict quality parameters by following proper quality management standards. Top notch quality manufacturing companies use high-quality ingredients, latest production machinery and a fully hygienic production environment to ensure good product strength, purity and stability by ensuring it all is managed by an expert at all steps.

There is always a quality check at each phase of manufacturing which involves raw material analysis, granulation inspection, uniformity analysis in blending and formulation, strength control in tablet compression and tablet weight, hardnes testing and disintegration and finishing product tests which are then finally approved with final packaging test. As a combination formulation, accuracy in blending is a key element for its proper composition.

A good manufacturing quality helps maintain a consistent strength, durability and reliability in the market and this is always valued greatly by distributors and franchise partners.

Packaging, Labelling and product presentation

Packaging greatly impacts Diclofenac Potassium 50 MG + Para 325 MG + Chlorzoxazone 20 MG Tabs product life and brand appeal. Blister packs, strip packs, and alu-alu packs are typically used as per the company need. Good packaging material helps the tablets stay safe from moisture, light and air and physical impact.

The labeling consists of Brand Name, Salt Names with their quantities, Batch number, manufacturing and expiry dates,MRP, storage requirements, and company name and details. Clean and bright printing and clearly marked information gives a product an professional appearance and builds good brand recognition.

As part of brand visibility for pharma companies, packaging gives a clear look to the product that is eye catching for consumers. The strip and cartton design adds a level of professional look that will improve product identification in the mass market. A good packaging always has to offer some added value along with its packaging features.

Market demand & business importance

Diclofenac Potassium 50 MG + Para 325 MG + Chlorzoxazone 20 MG Tabs is in high demand in the pharmaceutical market due to a wide coverage in general medicine portfolio for most businesses. The presence of such an active combination in the market makes it good for building strength in the pain management and skeletal muscle product segment. The combo strength and composition give good business value for wholesalers, distributors, retailers, and the PCD pharma franchises working all over the nation.

Companies invest in this formulation to complete their range and expand their offering of general medicines as well. Building a strong, reliable and in-demand product portfolio with fast-selling components helps a lot in gaining regular business and covering markets in a wide scope.

Having reliable and standard manufactured product with an attractive brand value helps a lot in gaining the trusts of its channel partners. Suitable for small and large pharma companies for boosting their general medicine products.

PCD pharma Franchise scope

Diclofenac Potassium 50 MG + Para 325 MG + Chlorzoxazone 20 MG Tabs has got really high prospects in the PCD pharma franchise market. It is a product falling in a regularly demanded segment and it needs only proper promotion by supporting visual aids, product cards, reminder cards, MR bags, and prescription pads.

For franchise distributors, this product has good commercial value and it could be the key to a robust medicine portfolio. A franchise partner gets good business benefits with good quality product at genuine rates, excellent packaging, assured quality manufacturing, monopoly and excellent delivery services with added promotional assistance.

A strong combo, well defined composition and good market relevance makes Diclofenac Potassium 50 MG + Para 325 MG + Chlorzoxazone 20 MG Tabs a very potent product for the PCD pharma franchise range.